Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Prepaid Assets (2019 - 2025)

Summit Therapeutics (SMMT) has disclosed Prepaid Assets for 7 consecutive years, with $7.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 214.98% year-over-year to $7.6 million, compared with a TTM value of $7.6 million through Sep 2025, up 214.98%, and an annual FY2024 reading of $11.1 million, up 322.43% over the prior year.
  • Prepaid Assets was $7.6 million for Q3 2025 at Summit Therapeutics, down from $11.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $11.1 million in Q4 2024 and bottomed at $409000.0 in Q1 2023.
  • Average Prepaid Assets over 5 years is $5.3 million, with a median of $5.3 million recorded in 2024.
  • The sharpest move saw Prepaid Assets plummeted 93.21% in 2022, then soared 1201.47% in 2024.
  • Year by year, Prepaid Assets stood at $7.2 million in 2021, then tumbled by 93.21% to $486000.0 in 2022, then surged by 439.51% to $2.6 million in 2023, then soared by 322.43% to $11.1 million in 2024, then tumbled by 31.46% to $7.6 million in 2025.
  • Business Quant data shows Prepaid Assets for SMMT at $7.6 million in Q3 2025, $11.0 million in Q2 2025, and $9.1 million in Q1 2025.